Ophthalmic Artery Occlusion: When the Cherry-Red Spot Disappears Too

Ophthalmic artery occlusion is a more devastating variant of acute retinal arterial occlusion.

It is distinguished from the more familiar central retinal artery occlusion by involving the ophthalmic artery itself.

This parent vessel supplies not only the central retinal artery, but the entire choroidal circulation via the posterior ciliary arteries.

Both the inner retina and the outer retina and choroid lose their blood supply at the same time.

The resulting vision loss is characteristically more profound, and the prognosis considerably worse, than in isolated central retinal artery occlusion.

Why Combined Involvement Matters

In isolated central retinal artery occlusion, the choroidal circulation remains intact, continuing to supply the outer retina.

This provides some degree of residual nutritional support.

In some cases, a collateral pathway, such as a cilioretinal artery, provides enough perfusion to preserve some central vision.

When the ophthalmic artery itself is occluded, this choroidal reserve is lost along with the retinal circulation.

This removes the partial protective mechanism that sometimes limits the severity of vision loss in a simple CRAO.

The result is typically more complete, more severe, and less recoverable vision loss.

Causes

• Embolic disease — from carotid atherosclerotic plaque or a cardiac source, the same general embolic mechanisms responsible for central retinal artery occlusion, but affecting a more proximal point in the arterial tree
• Giant cell arteritis — a critical cause to consider and urgently exclude in any older patient, given the immediate treatment implications and the risk of fellow-eye or other vascular territory involvement if untreated, discussed in more detail in this site’s coverage of arteritic anterior ischemic optic neuropathy
• Carotid artery dissection
• Orbital or periocular trauma, including, notably, iatrogenic cases following cosmetic facial filler injection, where inadvertent intravascular injection and retrograde embolization into the ophthalmic artery has become an increasingly recognized cause
• Hypercoagulable states and other less common causes of arterial occlusion

Clinical Presentation

Patients present with sudden, severe, typically profound monocular vision loss.

This is often more complete than the vision loss described in isolated central retinal artery occlusion.

Pain may accompany the event when the underlying cause is inflammatory, such as giant cell arteritis.

It can also accompany an embolic event with associated ocular ischemia.

Given the severity and the differential that includes giant cell arteritis, associated systemic symptoms should be specifically asked about.

These include headache, jaw claudication, scalp tenderness, and malaise.

This is because their presence or absence meaningfully changes the urgency and nature of the workup.

Exam Findings

• Marked, often severe reduction in visual acuity, frequently worse than typically seen in isolated central retinal artery occlusion
• Diffuse retinal whitening/edema affecting essentially the entire posterior pole, reflecting combined retinal and choroidal ischemia rather than the retinal-only whitening of simple CRAO
• Absence of a cherry-red spot in many cases, or a less distinct one than classically described in isolated CRAO — since the cherry-red spot itself depends on relatively preserved choroidal perfusion showing through a thin fovea against surrounding opaque, ischemic retina, and this contrast is lost when the choroid is also ischemic
• A marked relative afferent pupillary defect, discussed in more detail in this site’s dedicated article on that sign
• Signs of associated anterior segment ischemia in more severe or prolonged cases, given the ophthalmic artery’s broader role in supplying anterior as well as posterior ocular structures

Differential Diagnosis

• Isolated central retinal artery occlusion — retinal whitening with a preserved, often prominent cherry-red spot, and generally somewhat less severe overall vision loss given intact choroidal perfusion
• Central retinal vein occlusion — a fundamentally different fundus appearance (widespread hemorrhage, disc edema, venous dilation) rather than the retinal whitening of arterial occlusion, and a different, though still often significant, degree and pattern of vision loss
• Vitreous hemorrhage or other media opacity — reduced vision without the characteristic fundus findings of arterial occlusion, generally distinguishable once adequate fundus visualization is obtained

Diagnostic Evaluation

Urgent evaluation for giant cell arteritis is essential in any older patient.

This includes inflammatory markers and, where clinical suspicion is significant, temporal artery biopsy.

This reflects the treatment urgency and the risk to the fellow eye if the diagnosis is missed.

Carotid imaging and a cardiac embolic workup follow the same general principles used for any acute arterial retinal occlusion.

These are appropriate once giant cell arteritis has been reasonably addressed.

This is given the shared embolic risk factors between ophthalmic and central retinal artery occlusion.

Management

As with central retinal artery occlusion generally, treatment options for established ophthalmic artery occlusion are limited.

The evidence supporting any specific intervention — ocular massage, anterior chamber paracentesis, hyperbaric oxygen — is weak.

This reflects the same fundamental challenge that affects management of acute retinal arterial occlusion overall.

Treatment is far more effective, in principle, before irreversible ischemic damage occurs rather than after.

If giant cell arteritis is suspected, immediate high-dose systemic corticosteroid therapy should not be delayed for biopsy confirmation.

This reflects the urgency of protecting the fellow eye from the same, often devastating, process.

Given the severity of vision loss and generally poor prognosis, the greater practical impact often lies in the broader workup.

This means identifying and addressing the underlying cause — giant cell arteritis, carotid disease, or a cardioembolic source.

Doing so helps prevent further vascular events, including stroke.

Stroke shares many of the same underlying risk factors, and represents a serious, sometimes more immediately life-threatening, associated risk.

References

• Hayreh SS. Ocular vascular occlusive disorders: natural history of visual outcome. Progress in Retinal and Eye Research.
• Beatty S, Au Eong KG. Acute occlusion of the retinal arteries: current concepts and recent advances in diagnosis and management. Journal of Accident & Emergency Medicine.
• American Academy of Ophthalmology. Basic and Clinical Science Course, Section 12: Retina and Vitreous.